Icure Pharmaceutical Calls Extraordinary General Meeting for Director Elections with Details to Be Decided
Icure Pharmaceutical's board resolved to convene an extraordinary general meeting on August 6, 2026.
The agenda includes the election of two inside directors and two outside directors as new appointments, but specific candidates and their backgrounds are to be finalized by a future board meeting.
The record date for shareholder voting is July 14, 2026, and the meeting will be held at Hotel Rivera in Gangnam-gu, Seoul.
[AI Summary]This disclosure is a procedural step announcing the decision to call an EGM with no confirmed capital changes or financial impact at this stage. The director nominees remain undetermined, making it impossible to assess potential shifts in management strategy. Investors should await further disclosures for concrete details.
KOSDAQ Filing Information
Resolution to Convene a General Meeting of Shareholders (Extraordinary General Meeting)